Anti-HIV Activity of Ocimum labiatum Extract and Isolated Pheophytin-a

Anti-HIV Activity of Ocimum labiatum Extract and Isolated Pheophytin-a

Ocimum plants are traditionally used to manage HIV/AIDS in various African countries. The effects of Ocimum labiatum extract on HIV-1 protease (PR) and reverse transcriptase (RT) is presented here along with characterization of an identified bioactive compound, achieved through 1H- and 13C-NMR. The...

Full description

Bibliographic Details
Main Authors:	Petrina Kapewangolo, Martha Kandawa-Schulz, Debra Meyer
Format:	Article
Language:	English
Published:	MDPI AG 2017-11-01
Series:	Molecules
Subjects:	Ocimum labiatum pheophytin-a HIV-1 protease HIV-1 reverse transcriptase HIV-1 replication real-time cell electronic sensing
Online Access:	https://www.mdpi.com/1420-3049/22/11/1763

Similar Items

Triterpenoids from Ocimum labiatum Activates Latent HIV-1 Expression In Vitro: Potential for Use in Adjuvant Therapy
by: Petrina Kapewangolo, et al.
Published: (2017-10-01)

Cytotoxic, Cytostatic and HIV-1 PR Inhibitory Activities of the Soft Coral Litophyton arboreum
by: Mona S. Ellithey, et al.
Published: (2013-12-01)

Prevalence of resistance-associated mutations in Human Immunodeficiency Virus type 1-positive individuals failing HAART in Rio de Janeiro, Brazil
by: Rafael Brandão Varella, et al.

Genotypic and phenotypic characteristics of HIV-1 clade C resistant variants selected in vitro against nucleoside and non-nucleoside inhibitors of reverse transcriptase
by: Loemba, Hugues D.
Published: (2001)

Genotyping and antiretroviral resistance profile test from HIV-1 samples in patients with therapeutic failure from CearÃ
by: Melissa Soares Medeiros
Published: (2006)

Characterization of HIV-1 Proviral Latency Induced Through APOBEC3 Mutagenesis and Reverse Transcriptase Error
by: Greig, Matthew
Published: (2020)

Genotype testing and antiretroviral resistance profiles from HIV-1 patients experiencing therapeutic failure in northeast Brazil
by: Melissa Soares Medeiros, et al.

A Computational Approach for the Prediction of HIV Resistance Based on Amino Acid and Nucleotide Descriptors
by: Olga Tarasova, et al.
Published: (2018-10-01)

Framework para classificação das mutações de vírus HIV
by: Ozahata, Mina Cintho
Published: (2014)

Identification of anti-HIV and anti-Reverse Transcriptase activity from Tetracera scandens
by: Hyeok Sang Kwon, et al.
Published: (2012-03-01)

Anti-HIV-1 reverse transcriptase property of some edible mushrooms in Asia
by: Khuanjarat Choengpanya, et al.
Published: (2021-05-01)

HIVprotI: an integrated web based platform for prediction and design of HIV proteins inhibitors
by: Abid Qureshi, et al.
Published: (2018-03-01)

Asymmetric conformational maturation of HIV-1 reverse transcriptase
by: Xunhai Zheng, et al.
Published: (2015-06-01)

Assessment of Nonnucleoside Inhibitors Binding to HIV-1 Reverse Transcriptase Using HYDE Scoring
by: Agata Paneth, et al.
Published: (2019-04-01)

Natural Plant Alkaloid (Emetine) Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity
by: Ana Luiza Chaves Valadão, et al.
Published: (2015-06-01)

Molecular Docking Studies of HIV-1 Resistance to Reverse Transcriptase Inhibitors: Mini-Review
by: Olga Tarasova, et al.
Published: (2018-05-01)

Improving fold resistance prediction of HIV-1 against protease and reverse transcriptase inhibitors using artificial neural networks
by: Olivier Sheik Amamuddy, et al.
Published: (2017-08-01)

Antiretroviral resistance and genetic diversity of human immunodeficiency virus type 1 isolates from the Federal District, Central Brazil
by: Daniela M Cerqueira, et al.
Published: (2004-12-01)

Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs
by: Bluma G. Brenner, et al.
Published: (2010-11-01)

The impact of infected T lymphocyte burst rate and viral shedding rate on optimal treatment scheduling in a human immunodeficiency virus infection
by: Anuraag Bukkuri
Published: (2020-09-01)

Binding of the Nonnucleoside Reverse Transcriptase Inhibitor Efavirenz to HIV-1 Reverse Transcriptase Monomers and Dimers
by: Braz, Valerie Ann
Published: (2010)

The role of the glycosyl moiety of myricetin derivatives in anti-HIV-1 activity in vitro
by: Joseph T. Ortega, et al.
Published: (2017-10-01)

Human immunodeficiency virus type 1 ((HIV-1) subtypes in the northwest region, Cameroon
by: Lem Edith Abongwa, et al.
Published: (2019-08-01)

HIV-1 RT-Associated RNase H review
by: Madonna M. A. Mitry, et al.
Published: (2018-06-01)

Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
by: Valeria Famiglini, et al.
Published: (2016-02-01)

The Lysine 65 Residue in HIV-1 Reverse Transcriptase Function and in Nucleoside Analog Drug Resistance
by: Scott J. Garforth, et al.
Published: (2014-10-01)

Moquiniastrum e Richterago (Asteraceae): estudo fitoquímico, quimiossistemático e atividades biológicas
by: Tamayose, Cinthia Indy
Published: (2019)

A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants
by: Johnson Barry C, et al.
Published: (2012-12-01)

Kinetic analysis of HIV-1 reverse transcriptase in the presence of non-nucleoside inhibitors
by: Wang, Louise Zhiying
Published: (2008)

THE CASE OF TRAUMATIC TRANSMISSION CHILD OF HUMAN IMMUNODEFICIENCY VIRUS
by: Yu. V. Ostankova, et al.
Published: (2016-12-01)

High Performance Liquid Chromatographic Assay for the Determination of Protease Inhibitors (PIs) and Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) in Human Plasma
by: Kantima Sangsiriwut, et al.
Published: (2020-07-01)

Spontaneous Mutations in HIV-1 Gag, Protease, RT p66 in the First Replication Cycle and How They Appear: Insights from an In Vitro Assay on Mutation Rates and Types
by: Joshua Yi Yeo, et al.
Published: (2021-12-01)

Non-enzymatic functions of retroviral integrase：next target for the novel anti-HIV drug development.
by: Takao eMasuda
Published: (2011-10-01)

Long-Acting Anti-HIV Drugs Targeting HIV-1 Reverse Transcriptase and Integrase
by: Kamal Singh, et al.
Published: (2019-04-01)

The Spirocyclic Imine from a Marine Benthic Dinoflagellate, Portimine, Is a Potent Anti-Human Immunodeficiency Virus Type 1 Therapeutic Lead Compound
by: Mai Izumida, et al.
Published: (2019-08-01)

Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors
by: Nicolas Sluis-Cremer, et al.
Published: (2013-11-01)

Per-residue energy decomposition pharmacophore model to enhance virtual screening in drug discovery: a study for identification of reverse transcriptase inhibitors as potential anti-HIV agents
by: Cele FN, et al.
Published: (2016-04-01)

HIV-1 RT Inhibitors with a Novel Mechanism of Action: NNRTIs that Compete with the Nucleotide Substrate
by: Giovanni Maga, et al.
Published: (2010-03-01)

A Computational Approach for the Prediction of Treatment History and the Effectiveness or Failure of Antiretroviral Therapy
by: Olga Tarasova, et al.
Published: (2020-01-01)

The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs
by: Giovanni Barillari
Published: (2020-05-01)

Cannot write session to /tmp/vufind_sessions/sess_js1uvbhdnevrdu5kipm4i0bp8r